Sarcoidosis and interstitial pulmonary fibrosis; Two distinct disorders or two ends of the same spectrum

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 5, 2011, Pages 303-307

  Shigemitsu, Hidenobu ^a   Azuma, Arata ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Idiopathic pulmonary fibrosis; lung transplantation; prostaglandin E 2; prostaglandin endoperoxide synthase 2; pulmonary fibrosis; sarcoidosis; usual interstitial pneumonia

Indexed keywords

PROSTAGLANDIN SYNTHASE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

CLINICAL EXAMINATION; COMPARATIVE STUDY; FIBROSING ALVEOLITIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; THORAX RADIOGRAPHY;

CYCLOOXYGENASE 2; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; POLYMORPHISM, GENETIC; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY;

EID: 80051769854     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283486d52     Document Type: Review

References (23)

1. Schwarz MI, King TE. Interstitial lung disease. 4th ed. Hamilton, Canada: BC Decker Inc; 2003:; pp. 40-41.
2. Sheffield EA. Pathology of sarcoidosis. Clin Chest Med 1997;18:741-754. (Pubitemid 27525439)
3. Nagai S, Nagao T, Hoshino Y, et al. Heterogeneity of pulmonary fibrosis: interstitial pneumonias and sarcoidosis. Curr Opin Pulm Med 2001;7:262-271. (Pubitemid 32929680)
4. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
5. Nunes H, Brillet P, Valeyre D, et al. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007;28:102-120. (Pubitemid 46364275)
6. Baughman RIP, Teirstein AS, Judson MA, et al. for the ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:204-211. (Pubitemid 37351542)
7. Nagai S, Shigematsu M, Hamada K, et al. Clinical courses and prognosis of pulmonary sarcoidosis. Curr Opin Pulm Med 1999;5:293-298.
8. Shigemitsu H, Oblad JM, Sharma OP, et al. Chronic interstitial pneumonitis in end-stage sarcoidosis. Eur Resp J 2010;35:695-697. This study examined lung explantsand clinical characteristics of patients with endstage sarcoidosis who underwent lung transplantion. Many of the participants were found to have chronic intersitital pneumonitis, some with UIP pattern, considered atypical in end-stage sarcoidosis. Patients in this group had shorter time from diagnosis to lung transplantion compared with the group with histological changes typical of end-stage sarcoidosis. Authors suggest there may be a subset of sarcoidosis patients with rapid progressive disease.
9. Costabel U, Bross KJ, Guzman J, et al. Predictive value of bronchoalveolar T-cell subsets for the course of pulmonary sarcoidosis. Ann N Y Acad Sci 1986;465:418-426. (Pubitemid 16006582)
10. Crystal RG, Roberts WC, Hunninghake GW, et al. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T lymphocytes. Ann Intern Med 1981;94:73-94. (Pubitemid 11218737)
11. Rosen Y, Athanassiades TJ, Moon S, et al. Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas. Chest 1978;74:122-125. (Pubitemid 8404844)
12. Abehsera M, Valeyre D, Grenier P, et al. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000;174:1751-1757. A review of CT patterns in 80 patients with fibrotic sarcoidosis and its correlation with pulmonary function test. Authors found three main abnormalities including bronchial distortions, honeycombing, and linear opacities. (Pubitemid 30346752)
13. Mathieson JR, Mayo JR, Staples CA, Muller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989;171:111-116. (Pubitemid 19093054)
14. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-196. (Pubitemid 34001280)
15. Raghu G, Mageto YN, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999;116:1168-1174. (Pubitemid 29535965)
16. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis-evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
17. Keerthisingam CV, Jenkins RG, Harrison NK, et al. Cyclooxygenase-2 defciency results in a loss of the antiproliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycininduced pulmonary fibrosis in mice. Am J Pathol 2001;158:1411-1422. (Pubitemid 32281305)
18. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, et al. Indomethacin suppresses the antiproliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J 1997;321:639-643. (Pubitemid 27084870)
19. Kolodsick JE, Peters-Golden M, Larios J, et al. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003;29:537-544. (Pubitemid 37357704)
20. Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 1982;257:8630-8633. (Pubitemid 12004184)
21. Wilborn J, Crofford LJ, Burdick MD, et al. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995;95:1861-1868.
22. Vancheri C, Sortino MA, Tomaselli V, et al. Different expression of TNF-alpha receptors and prostaglandin E (2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 2000;22:628-634. (Pubitemid 30319550)
23. Hill MR, Papafili A, Booth H, et al. Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006;174:915-922. This study identified polymorphism to the promotor gene of PTSG2,-765 G>C, to correlate with disease susceptibility and progression. Authors suggested that genotype analysis of patients with sarcoidosis for-765C allele may provide useful prognostic information. (Pubitemid 44564792)